{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:55:55Z","timestamp":1774396555380,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["KYCX20_2444"],"award-info":[{"award-number":["KYCX20_2444"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation and Entrepreneurship Training Programme for University Students","award":["202410313036Z"],"award-info":[{"award-number":["202410313036Z"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101263"],"award-info":[{"award-number":["82101263"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16556-7","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:33:29Z","timestamp":1755801209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["GDNF attenuates a-synuclein aggregation-induced damage to VTA-NAc dopaminergic transmission and alleviates depression-like behaviors in mice"],"prefix":"10.1038","volume":"15","author":[{"given":"Jing","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maokang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengzhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zifan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanxu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanjian","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanxi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"16556_CR1","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"M Hayes","year":"2019","unstructured":"Hayes, M. Parkinson\u2019s disease and parkinsonism. Am. J. Med. 132, 802\u2013807. https:\/\/doi.org\/10.1016\/j.amjmed.2019.03.001 (2019).","journal-title":"Am. J. Med."},{"key":"16556_CR2","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/mds.23815","volume":"26","author":"F Assogna","year":"2011","unstructured":"Assogna, F., Cravello, L., Caltagirone, C. & Spalletta, G. Anhedonia in parkinson\u2019s disease: a systematic review of the literature. Mov. Disord. 26, 1825\u20131834. https:\/\/doi.org\/10.1002\/mds.23815 (2011).","journal-title":"Mov. Disord"},{"key":"16556_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2174\/1570159X17666191016094857","volume":"18","author":"F Assogna","year":"2020","unstructured":"Assogna, F. et al. Drug choices and advancements for managing depression in parkinson\u2019s disease. Curr. Neuropharmacol. 18, 277\u2013287. https:\/\/doi.org\/10.2174\/1570159X17666191016094857 (2020).","journal-title":"Curr. Neuropharmacol."},{"key":"16556_CR4","doi-asserted-by":"publisher","first-page":"21r14328","DOI":"10.4088\/JCP.21r14328","volume":"83","author":"AM Arnaud","year":"2022","unstructured":"Arnaud, A. M. et al. Impact of major depressive disorder on comorbidities: A systematic literature review. J. Clin. Psychiatry. 83, 21r14328. https:\/\/doi.org\/10.4088\/JCP.21r14328 (2022).","journal-title":"J. Clin. Psychiatry"},{"key":"16556_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/psyg.12014","volume":"13","author":"H Hori","year":"2013","unstructured":"Hori, H. & Kunugi, H. Dopamine agonist-responsive depression. Psychogeriatrics 13, 189\u2013195. https:\/\/doi.org\/10.1111\/psyg.12014 (2013).","journal-title":"Psychogeriatrics"},{"key":"16556_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fnana.2011.00041","volume":"5","author":"M Lobo","year":"2011","unstructured":"Lobo, M. & Nestler, E. The striatal balancing act in drug addiction: distinct roles of direct and indirect pathway medium spiny neurons. Front. Neuroanat. 5, 41. https:\/\/doi.org\/10.3389\/fnana.2011.00041 (2011).","journal-title":"Front. Neuroanat."},{"key":"16556_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neubiorev.2019.10.015","volume":"108","author":"E Douma","year":"2020","unstructured":"Douma, E. & de Kloet, E. Stress-induced plasticity and functioning of ventral tegmental dopamine neurons. Neurosci. Biobehav Rev. 108, 48\u201377. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.10.015 (2020).","journal-title":"Neurosci. Biobehav Rev."},{"key":"16556_CR8","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nature11713","volume":"493","author":"D Chaudhury","year":"2013","unstructured":"Chaudhury, D. et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 493, 532\u2013536. https:\/\/doi.org\/10.1038\/nature11713 (2013).","journal-title":"Nature"},{"issue":"Suppl 2","key":"16556_CR9","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/00019052-200312002-00002","volume":"16","author":"A Nieoullon","year":"2003","unstructured":"Nieoullon, A. & Coquerel, A. Dopamine: a key regulator to adapt action, emotion, motivation and cognition. Curr. Opin. Neurol. 16 (Suppl 2), S3\u20139 (2003).","journal-title":"Curr. Opin. Neurol."},{"key":"16556_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s002130100836","volume":"159","author":"C Renard","year":"2001","unstructured":"Renard, C., Fiocco, A., Clenet, F., Hascoet, M. & Bourin, M. Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test? Psychopharmacol. (Berl). 159, 42\u201350. https:\/\/doi.org\/10.1007\/s002130100836 (2001).","journal-title":"Psychopharmacol. (Berl)"},{"key":"16556_CR11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1046\/j.0953-816x.2001.01698.x","volume":"14","author":"E Pallis","year":"2001","unstructured":"Pallis, E., Thermos, K. & Spyraki, C. Chronic Desipramine treatment selectively potentiates somatostatin-induced dopamine release in the nucleus accumbens. Eur. J. Neurosci. 14, 763\u2013767. https:\/\/doi.org\/10.1046\/j.0953-816x.2001.01698.x (2001).","journal-title":"Eur. J. Neurosci."},{"key":"16556_CR12","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41380-024-02476-x","volume":"29","author":"N Song","year":"2024","unstructured":"Song, N. et al. NAc-DBS corrects depression-like behaviors in CUMS mouse model via disinhibition of DA neurons in the VTA. Mol. Psychiatr. 29, 1550\u20131566. https:\/\/doi.org\/10.1038\/s41380-024-02476-x (2024).","journal-title":"Mol. Psychiatr"},{"key":"16556_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/npp.2009.93","volume":"35","author":"S Sesack","year":"2010","unstructured":"Sesack, S. & Grace, A. Cortico-Basal ganglia reward network: microcircuitry. Neuropsychopharmacology 35, 27\u201347. https:\/\/doi.org\/10.1038\/npp.2009.93 (2010).","journal-title":"Neuropsychopharmacology"},{"key":"16556_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1749-6632.1999.tb09266.x","volume":"877","author":"G Meredith","year":"1999","unstructured":"Meredith, G. The synaptic framework for chemical signaling in nucleus accumbens. Ann. N Y Acad. Sci. 877, 140\u2013156. https:\/\/doi.org\/10.1111\/j.1749-6632.1999.tb09266.x (1999).","journal-title":"Ann. N Y Acad. Sci."},{"key":"16556_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1080\/10253890.2019.1673361","volume":"23","author":"H Qiao","year":"2020","unstructured":"Qiao, H., Yang, S., Xu, C., Ma, X. & An, S. Involvement of D2 receptor in the NAc in chronic unpredictable stress-induced depression-like behaviors. Stress 23, 318\u2013327. https:\/\/doi.org\/10.1080\/10253890.2019.1673361 (2020).","journal-title":"Stress"},{"key":"16556_CR16","doi-asserted-by":"publisher","first-page":"959224","DOI":"10.3389\/fnmol.2022.959224","volume":"15","author":"Y Qin","year":"2022","unstructured":"Qin, Y. et al. Repeated Inhibition of sigma-1 receptor suppresses GABAA receptor expression and long-term depression in the nucleus accumbens leading to depressive-like behaviors. Front. Mol. Neurosci. 15, 959224. https:\/\/doi.org\/10.3389\/fnmol.2022.959224 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"16556_CR17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jagp.2018.10.015","volume":"27","author":"M Ishiguro","year":"2019","unstructured":"Ishiguro, M. et al. Increased serum levels of \u03b1-Synuclein in patients with major depressive disorder. Am. J. Geriatric Psychiatry. 27, 280\u2013286. https:\/\/doi.org\/10.1016\/j.jagp.2018.10.015 (2019).","journal-title":"Am. J. Geriatric Psychiatry"},{"key":"16556_CR18","doi-asserted-by":"publisher","first-page":"17648","DOI":"10.1074\/jbc.M110.100867","volume":"285","author":"H Lou","year":"2010","unstructured":"Lou, H. et al. Serine 129 phosphorylation reduces the ability of \u03b1-Synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo. J. Biol. Chem. 285, 17648\u201317661. https:\/\/doi.org\/10.1074\/jbc.M110.100867 (2010).","journal-title":"J. Biol. Chem."},{"key":"16556_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neulet.2009.10.010","volume":"467","author":"A Jeannotte","year":"2009","unstructured":"Jeannotte, A., McCarthy, J. & Sidhu, A. Desipramine induced changes in the norepinephrine transporter, alpha- and gamma-synuclein in the hippocampus, amygdala and striatum. Neurosci. Lett. 467, 86\u201389. https:\/\/doi.org\/10.1016\/j.neulet.2009.10.010 (2009).","journal-title":"Neurosci. Lett."},{"key":"16556_CR20","doi-asserted-by":"publisher","first-page":"661656","DOI":"10.3389\/fcell.2021.661656","volume":"9","author":"R Lara-Rodarte","year":"2021","unstructured":"Lara-Rodarte, R. et al. Mouse embryonic stem cells expressing GDNF show enhanced dopaminergic differentiation and promote behavioral recovery after grafting in parkinsonian rats. Front. Cell. Dev. Biol. 9, 661656. https:\/\/doi.org\/10.3389\/fcell.2021.661656 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"16556_CR21","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.4103\/1673-5374.355816","volume":"18","author":"CX Tang","year":"2023","unstructured":"Tang, C. X. et al. Blunt dopamine transmission due to decreased GDNF in the PFC evokes cognitive impairment in parkinson\u2019s disease. Neural Regen Res. 18, 1107\u20131117. https:\/\/doi.org\/10.4103\/1673-5374.355816 (2023).","journal-title":"Neural Regen Res."},{"key":"16556_CR22","doi-asserted-by":"publisher","first-page":"951","DOI":"10.4158\/EP-2018-0492","volume":"25","author":"Y Yang","year":"2019","unstructured":"Yang, Y. et al. The association of decreased serum Gdnf level with hyperglycemia and depression in type 2 diabetes mellitus. Endocr. Pract. 25, 951\u2013965. https:\/\/doi.org\/10.4158\/EP-2018-0492 (2019).","journal-title":"Endocr. Pract."},{"key":"16556_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41398-024-02942-8","volume":"14","author":"BN Ozkan","year":"2024","unstructured":"Ozkan, B. N. et al. Altered blood parameters in major depression patients receiving repetitive transcranial magnetic stimulation (rTMS) therapy: a randomized case-control study. Transl Psychiatry. 14, 264. https:\/\/doi.org\/10.1038\/s41398-024-02942-8 (2024).","journal-title":"Transl Psychiatry"},{"key":"16556_CR24","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1002\/mds.28258","volume":"35","author":"P Chmielarz","year":"2020","unstructured":"Chmielarz, P. et al. GDNF\/RET signaling pathway activation eliminates lewy body pathology in midbrain dopamine neurons. Mov. Disord. 35, 2279\u20132289. https:\/\/doi.org\/10.1002\/mds.28258 (2020).","journal-title":"Mov. Disord"},{"key":"16556_CR25","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.3390\/ijms25063219","volume":"25","author":"RM Brazdis","year":"2024","unstructured":"Brazdis, R. M., von Zimmermann, C., Lenz, B., Kornhuber, J. & Muhle, C. Peripheral upregulation of parkinson\u2019s Disease-Associated genes encoding alpha-Synuclein, beta-Glucocerebrosidase, and ceramide glucosyltransferase in major depression. Int. J. Mol. Sci. 25, 3219. https:\/\/doi.org\/10.3390\/ijms25063219 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"16556_CR26","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.3390\/ijms20082029","volume":"20","author":"A Rotter","year":"2019","unstructured":"Rotter, A. et al. Alpha-Synuclein RNA expression is increased in major depression. Int. J. Mol. Sci. 20, 2029. https:\/\/doi.org\/10.3390\/ijms20082029 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"16556_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/jnc.14810","volume":"150","author":"D Sulzer","year":"2019","unstructured":"Sulzer, D. & Edwards, R. H. The physiological role of alpha-synuclein and its relationship to parkinson\u2019s disease. J. Neurochem. 150, 475\u2013486. https:\/\/doi.org\/10.1111\/jnc.14810 (2019).","journal-title":"J. Neurochem"},{"key":"16556_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/jnc.13570","volume":"137","author":"MJ Benskey","year":"2016","unstructured":"Benskey, M. J., Perez, R. G. & Manfredsson, F. P. The contribution of alpha synuclein to neuronal survival and function - Implications for parkinson\u2019s disease. J. Neurochem. 137, 331\u2013359. https:\/\/doi.org\/10.1111\/jnc.13570 (2016).","journal-title":"J. Neurochem"},{"key":"16556_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41531-025-00998-x","volume":"11","author":"D Xia","year":"2025","unstructured":"Xia, D. et al. Chronic stress induces depression-like behaviors and parkinsonism via upregulating alpha-synuclein. NPJ Parkinsons Dis. 11, 139. https:\/\/doi.org\/10.1038\/s41531-025-00998-x (2025).","journal-title":"NPJ Parkinsons Dis."},{"key":"16556_CR30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3390\/biomedicines11020541","volume":"11","author":"L Miquel-Rio","year":"2023","unstructured":"Miquel-Rio, L., Sarries-Serrano, U., Pavia-Collado, R., Meana, J. J. & Bortolozzi, A. The role of alpha-Synuclein in the regulation of serotonin system: physiological and pathological features. Biomedicines 11, 541. https:\/\/doi.org\/10.3390\/biomedicines11020541 (2023).","journal-title":"Biomedicines"},{"key":"16556_CR31","first-page":"87","volume":"12","author":"W Yu","year":"2019","unstructured":"Yu, W., Yang, W., Li, X., Li, X. & Yu, S. Alpha-synuclein oligomerization increases its effect on promoting NMDA receptor internalization. Int. J. Clin. Exp. Pathol. 12, 87\u2013100 (2019).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"16556_CR32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0006-8993(94)91874-0","volume":"640","author":"J Desce","year":"1994","unstructured":"Desce, J., Godeheu, G., Galli, T., Glowinski, J. & Cheramy, A. Opposite presynaptic regulations by glutamate through NMDA receptors of dopamine synthesis and release in rat striatal synaptosomes. Brain Res. 640, 205\u2013214. https:\/\/doi.org\/10.1016\/0006-8993(94)91874-0 (1994).","journal-title":"Brain Res."},{"key":"16556_CR33","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burre","year":"2010","unstructured":"Burre, J. et al. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329, 1663\u20131667. https:\/\/doi.org\/10.1126\/science.1195227 (2010).","journal-title":"Science"},{"key":"16556_CR34","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1016\/j.cub.2014.08.027","volume":"24","author":"L Wang","year":"2014","unstructured":"Wang, L. et al. alpha-synuclein multimers cluster synaptic vesicles and attenuate recycling. Curr. Biol. 24, 2319\u20132326. https:\/\/doi.org\/10.1016\/j.cub.2014.08.027 (2014).","journal-title":"Curr. Biol."},{"key":"16556_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.brainresbull.2020.02.001","volume":"157","author":"K Jayaramayya","year":"2020","unstructured":"Jayaramayya, K. et al. Unraveling correlative roles of dopamine transporter (DAT) and parkin in parkinson\u2019s disease (PD) - A road to discovery? Brain Res. Bull. 157, 169\u2013179. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.02.001 (2020).","journal-title":"Brain Res. Bull."},{"key":"16556_CR36","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.nbd.2005.08.005","volume":"21","author":"E Unger","year":"2006","unstructured":"Unger, E. et al. Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice. Neurobiol. Dis. 21, 431\u2013443. https:\/\/doi.org\/10.1016\/j.nbd.2005.08.005 (2006).","journal-title":"Neurobiol. Dis."},{"key":"16556_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neubiorev.2011.04.012","volume":"36","author":"S Cabib","year":"2012","unstructured":"Cabib, S. & Puglisi-Allegra, S. The mesoaccumbens dopamine in coping with stress. Neurosci. Biobehav Rev. 36, 79\u201389. https:\/\/doi.org\/10.1016\/j.neubiorev.2011.04.012 (2012).","journal-title":"Neurosci. Biobehav Rev."},{"key":"16556_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.biopsych.2006.05.031","volume":"61","author":"A Gershon","year":"2007","unstructured":"Gershon, A., Vishne, T. & Grunhaus, L. Dopamine D2-like receptors and the antidepressant response. Biol. Psychiatry. 61, 145\u2013153. https:\/\/doi.org\/10.1016\/j.biopsych.2006.05.031 (2007).","journal-title":"Biol. Psychiatry"},{"key":"16556_CR39","doi-asserted-by":"publisher","first-page":"6828","DOI":"10.1523\/JNEUROSCI.5310-08.2009","volume":"29","author":"B Meurers","year":"2009","unstructured":"Meurers, B. et al. Dopamine depletion induces distinct compensatory gene expression changes in DARPP-32 signal transduction cascades of striatonigral and striatopallidal neurons. J. Neurosci. 29, 6828\u20136839. https:\/\/doi.org\/10.1523\/JNEUROSCI.5310-08.2009 (2009).","journal-title":"J. Neurosci."},{"key":"16556_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fnmol.2017.00247","volume":"10","author":"T Zhang","year":"2017","unstructured":"Zhang, T. et al. MPTP-Induced dopamine depletion in basolateral amygdala via decrease of D2R activation suppresses GABA(A) receptors expression and LTD induction leading to Anxiety-Like behaviors. Front. Mol. Neurosci. 10, 247. https:\/\/doi.org\/10.3389\/fnmol.2017.00247 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"16556_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","volume":"45","author":"M Hamon","year":"2013","unstructured":"Hamon, M. & Blier, P. Monoamine neurocircuitry in depression and strategies for new treatments. Prog Neuropsychopharmacol. Biol. Psychiatry. 45, 54\u201363. https:\/\/doi.org\/10.1016\/j.pnpbp.2013.04.009 (2013).","journal-title":"Prog Neuropsychopharmacol. Biol. Psychiatry"},{"key":"16556_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/2045125317737264","volume":"8","author":"SS Clevenger","year":"2018","unstructured":"Clevenger, S. S., Malhotra, D., Dang, J., Vanle, B. & IsHak, W. W. The role of selective serotonin reuptake inhibitors in preventing relapse of major depressive disorder. Ther. Adv. Psychopharmacol. 8, 49\u201358. https:\/\/doi.org\/10.1177\/2045125317737264 (2018).","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"16556_CR43","doi-asserted-by":"publisher","first-page":"734","DOI":"10.14348\/molcells.2015.0131","volume":"38","author":"MY Lee","year":"2015","unstructured":"Lee, M. Y., Hong, S., Kim, N., Shin, K. S. & Kang, S. J. Tricyclic antidepressants amitriptyline and Desipramine induced neurotoxicity associated with parkinson\u2019s disease. Mol. Cells. 38, 734\u2013740. https:\/\/doi.org\/10.14348\/molcells.2015.0131 (2015).","journal-title":"Mol. Cells"},{"key":"16556_CR44","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1016\/j.febslet.2015.11.006","volume":"589","author":"ER Kramer","year":"2015","unstructured":"Kramer, E. R. & Liss, B. GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease. FEBS Lett. 589, 3760\u20133772. https:\/\/doi.org\/10.1016\/j.febslet.2015.11.006 (2015).","journal-title":"FEBS Lett."},{"key":"16556_CR45","doi-asserted-by":"publisher","first-page":"e14461","DOI":"10.1111\/cns.14461","volume":"30","author":"C Tang","year":"2024","unstructured":"Tang, C. et al. Distinct serum GDNF coupling with brain structural and functional changes underlies cognitive status in parkinson\u2019s disease. CNS Neurosci. Ther. 30, e14461. https:\/\/doi.org\/10.1111\/cns.14461 (2024).","journal-title":"CNS Neurosci Ther."},{"key":"16556_CR46","doi-asserted-by":"publisher","first-page":"1136499","DOI":"10.3389\/fnins.2023.1136499","volume":"17","author":"SY Tong","year":"2023","unstructured":"Tong, S. Y. et al. Serum glial cell line-derived neurotrophic factor (GDNF) a potential biomarker of executive function in parkinson\u2019s disease. Front. Neurosci. 17, 1136499. https:\/\/doi.org\/10.3389\/fnins.2023.1136499 (2023).","journal-title":"Front. Neurosci."},{"key":"16556_CR47","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.pneurobio.2011.01.006","volume":"93","author":"MR Bennett","year":"2011","unstructured":"Bennett, M. R. The prefrontal-limbic network in depression: modulation by hypothalamus, basal ganglia and midbrain. Prog Neurobiol. 93, 468\u2013487. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.01.006 (2011).","journal-title":"Prog Neurobiol."},{"key":"16556_CR48","doi-asserted-by":"publisher","unstructured":"Knezevic, E., Nenic, K., Milanovic, V. & Knezevic, N. N. The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders. Cells. 12, 2726. https:\/\/doi.org\/10.3390\/cells12232726 (2023).","DOI":"10.3390\/cells12232726"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16556-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16556-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16556-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:56:49Z","timestamp":1757444209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16556-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16556"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16556-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experimentation procedures were conducted in accordance with the guidelines for the Care and Use of Laboratory Animals developed by the National Institutes of Health and approved by the Institutional Animal Care and Use Committee of Xuzhou Medical University (approval number: 202209S042).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the consent for publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30804"}}